Gilyazova, I.R.,
Ivanova, E.A.,
Bermisheva, M.A.,
Loginova, M.V.,
Asadullina, D.D.,
Ishemgulov, R.R.,
Mustafin, A.T.,
Pavlov, V.N.,
Khusnutdinova, E.K. (2022) in the group of patients compared with the control (OR = 0.74, 95%CI = 0.55–0.
99, p = 0.05). When stratifying
rs2794521-rs1130864 were more common among MetS patients (OR=1.
99, p=0.032). T-T haplotype in CRP
Dobrodeeva, V.S.,
Shnayder, N.A.,
Novitsky, M.A.,
Asadullin, A.R.,
Vaiman, E.E.,
Petrova, M.M.,
Limankin, O.V.,
Neznanov, N.G.,
Garganeeva, N.P.,
Nasyrova, R.F. (2022) in Russian patients with SSDs. Methods: We examined
99 patients with SSDs (mean age—24.56 years old
KHABIBOV, M.,
GARIFULLIN, A.,
KHAMITOV, F.,
KHALIKOVA, L.,
BOUMBER, Y.,
KHADDOUR, K.,
FERNANDEZ, M.,
KUZNETSOVA, N.,
KIT, O.,
KHARIN, L. (2022) pathway disruptions (NF‑κB, Wnt, PI3K/AKT/
mTOR)
involved in the formation of GBM were discussed. Current